In The News - Technology
NECN | January 25, 2019
An overview of Quanterix’ story, detailing our groundbreaking Simoa technology, the process of measuring biomarkers to detect and advance the treatment of disease, as well as the real world applications of how our technology is impacting how health care is practiced.
Genome Web | January 10, 2019
Jan 10, 2019 | Monica Heger
January 09, 2019
CEO Kevin Hrusovsky wows a packed audience with Quanterix' vision and progress towards transforming healthcare at the 2019 J.P. Morgan Health Conference in San Francisco.
David Walt and George Church receive grant from Chan Zuckerberg Initiative to enable better diagnosis and monitoring of Parkinson’s disease
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
FierceBiotech | November 19, 2018
by Conor Hale
PharmaVOICE | November 16, 2018
Contributed by: Denise Myshko
September 25, 2018
In a recent interview with Baystate Business, Kevin Hrusovsky, Quanterix Chairman and CEO and founder of Powering Precision Health, explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced. Click the file below to hear the interview.
Digital Biotech | September 07, 2018
Kevin Hrusovsky, Quanterix Chairman and CEO and Founder of Powering Precision Health, recently sat down with TetraScience CEO Alok Tayi to talk about the exciting work that Quanterix is doing in the area of clinical biomarkers and the business of diagnostics, as well as healthcare, more broadly,
SelectScience Interview | January 29, 2018
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix